Michael Biron, MBA, is the Chief Executive Officer and a co-founder of Altis Biosystems and has over 13 years of operational management experience in a variety of settings. He is a former U.S. Army Officer, with experience in project management, logistics, and leadership development. While serving in the army, he was responsible for managing up to 50 personnel, while stationed at home, and overseas. Prior to the military, Michael spent several years as a top sales representative. He also worked in construction management, and was responsible for overseeing a variety of residential, multifamily, and commercial interior construction projects valued up to $26M. He has a bachelor’s degree from Penn State and an MBA from UNC Kenan-Flagler Business School, with a concentration in entrepreneurship.
Dr. Christopher Sims, MD, is the President and a co-founder of Altis Biosystems, LLC and is a Professor at the University of North Carolina with joint appointments in the Departments of Chemistry and Medicine. He holds a BS in Physical Sciences (Chemistry) from Auburn University and an MD from Johns Hopkins University. He completed a medical residency at the Beth Israel Hospital, Harvard University, and postdoctoral clinical fellowships in medicine and in rheumatology at Stanford University Hospital. His postdoctoral research work was in Physiology and Biophysics at the University of California, Irvine where he remained on faculty until his move to UNC-Chapel Hill in 2007. His current research is aimed at the development of cell-based assays and microfabricated technologies for clinical and biomedical applications, particularly in the field of stem-cell research. Dr. Sims has been the scientific co-founder of three prior companies: Cell Biosciences (currently Protein Simple); Intellego, Inc.; and Cell Microsystems, Inc.
Yuli Wang, PhD, is the Chief Science Officer and a co-founder of Altis Biosystems, LLC and works with Drs. Allbritton and Sims in developing new technologies to address important biomedical problems. Dr. Wang has experience in entrepreneurship development activities and has co-founded three university spin-off companies: Intellego Corporation (in 2005 which later became a subsidiary of Amkor Technology), Cell Microsystems (in 2010), and Altis Biosystems (in 2016). Dr. Wang obtained his Ph.D. from University of California, Irvine.
Dr. Nancy Allbritton, PhD, MD, is a co-founder of Altis Biosystems and the Kenan Professor and Chair of the Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill (UNC) and North Carolina State University (NC State). She obtained her Ph.D. in Medical Physics/Medical Engineering from the Massachusetts Institute of Technology, and her M.D. from the Johns Hopkins University. She is a Fellow in the American Institute for Medical & Biological Engineering and the AAAS, a member of the National Academy of Inventors and recipient of the 2016 ACS Award in Chemical Instrumentation. Dr. Allbritton’s research and commercialization efforts are directed at the development of new technologies by bringing to bear methods from engineering, chemistry, physics and biology to address biomedical problems. She is a founder of three prior companies, including Cell Biosciences (now Protein Simple), Intellego, and Cell Microsystems.
Scott Magness, Ph.D., is a co-founder of Altis Biosystems and an Associate Professor inthe Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill (UNC) and North Carolina State University (NC State), and Departments of Medicine, and Cell Biology & Physiology at UNC. He obtained his Ph.D. in Genetics & Molecular Biology from UNC Chapel Hill. Dr. Magness’ expertise isin stem cell biology, intestinal physiology, single-cell genomics, and high-throughout platforms to study factors that influence GI stem cell maintenance & differentiation and the microbiome. Heis a member of the UNC Lineburger Cancer Center and has additional research programs focused on the cell-of-origin for Gastrointestinal Neuroendocrine and gastric cancer.At Altis, he advises on primary gut cultures and the biology underling RepliGut. Dr. Magness is also the founder of SeqQuest LLC, that provides a software solution for high-dimensional data visualization.